Concepts (448)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with MICHELLE A FANALE's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MICHELLE A FANALE has written about over time.
Antibodies, Monoclonal, Murine-DerivedPregnancy Complications, NeoplasticLymphoma, Non-HodgkinLymphomaAdultKi-1 AntigenLymphoma, T-CellImmunoconjugatesLymphoma, Large B-Cell, DiffuseRituximabMediastinal NeoplasmsLymphoma, Large-Cell, AnaplasticAntineoplastic Combined Chemotherapy ProtocolsHodgkin DiseaseVincristinePrednisoneCyclophosphamideDoxorubicinLymphoma, T-Cell, Peripheral
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Antibodies, Monoclonal, Murine-Derived | 12 | 2012 | 2017 | March 2014 |
| Pregnancy Complications, Neoplastic | 4 | 2005 | 2017 | March 2014 |
| Lymphoma, Non-Hodgkin | 11 | 2007 | 2019 | July 2015 |
| Lymphoma | 14 | 2012 | 2019 | October 2015 |
| Adult | 109 | 1996 | 2024 | February 2016 |
| Ki-1 Antigen | 10 | 2011 | 2022 | March 2016 |
| Lymphoma, T-Cell | 6 | 2015 | 2019 | May 2016 |
| Immunoconjugates | 21 | 2011 | 2023 | May 2016 |
| Lymphoma, Large B-Cell, Diffuse | 14 | 2011 | 2022 | June 2016 |
| Rituximab | 28 | 2012 | 2022 | July 2016 |
| Mediastinal Neoplasms | 5 | 2015 | 2019 | December 2016 |
| Lymphoma, Large-Cell, Anaplastic | 9 | 2012 | 2022 | December 2016 |
| Antineoplastic Combined Chemotherapy Protocols | 77 | 2005 | 2024 | January 2017 |
| Hodgkin Disease | 65 | 2008 | 2024 | February 2017 |
| Vincristine | 19 | 2013 | 2022 | August 2017 |
| Prednisone | 16 | 2013 | 2023 | September 2017 |
| Cyclophosphamide | 23 | 2013 | 2023 | November 2017 |
| Doxorubicin | 36 | 2012 | 2023 | November 2017 |
| Lymphoma, T-Cell, Peripheral | 13 | 2014 | 2023 | September 2018 |
To return to the timeline,
click here.